Canagliflozin Coupon - Canagliflozin 300mg tablet


Canagliflozin (Invokana) is an expensive drug used to treat type 2 diabetes. It helps to control blood sugar. This drug is more popular than comparable drugs. There are currently no generic alternatives to Invokana. It is covered by most Medicare and insurance plans, but some pharmacy coupons or cash prices may be lower. The lowest GoodRx price for the most common version of Invokana is around $469.88, 18% off the average retail price of $579.62. Compare SGLT2 inhibitors.
Canagliflozin Coupon - Canagliflozin 300mg tablet

Insurance Coverage: Many major insurance plans no longer cover Invokana. Learn More

Canagliflozin Latest News

Get the latest updates on this drug from the GoodRx medical team

Why Taking Your Medications for These Common “Silent” Diseases is Important

Roni Shye - January 16, 2018

If you’ve ever been afraid to show up at your doctor’s office because you’ve been “bad” then this post is for YOU!  You may think your doctor is “pushing medications on you” especially if you aren’t experiencing any symptoms of the condition they are treating you for. However, their reasoning is not without sound medical and professional judgment. 

One of the many reasons you might receive a lecture about the importance of taking your medications is due to the progressive nature of many diseases if not properly treated. See More

Updated FDA Safety Alert: Invokana and Invokamet for Diabetes

Roni Shye - June 21, 2017

On May 16th, 2017, the FDA issued an update on canagliflozin-containing medications, like Invokana and Invokamet, as part of a year-long ongoing review.

This update is the result of new data from the CANVAS and CANVAS-R clinical trials. This research showed that leg and foot amputations occurred two times more often in patients treated with canagliflozin than in patients who were given a placebo sugar pill. See More

New FDA Safety Alert: Invokana and Farxiga for Diabetes

Roni Shye - July 06, 2016

In June 2016, the FDA issued a safety alert for canagliflozin (Invokana, Invokamet), used to treat type 2 diabetes.

Now, another warning has been issued, for Invokana and Invokamet along with another similar diabetes medication, dapagliflozin (Farxiga and Xigduo XR).

According to the FDA, canagliflozin and dapagliflozin may cause an increased risk of acute kidney injury. The previous warning for canagliflozin was for an increased risk of foot and leg amputations—all serious stuff. See More

FDA Safety Alert: Invokana and Invokamet for Diabetes

Roni Shye - June 08, 2016

The FDA has issued a safety alert for medications containing canagliflozin, a newer drug used to treat type 2 diabetes.

According to the FDA, medications containing canagliflozin (Invokana and Invokamet) may cause an increased risk of leg and foot amputations.

Do diabetics already have an increased risk of leg and foot amputations?

Yes. Diabetics have a higher risk of leg and foot amputations compared to a person who does not have diabetes. See More

50+ Drugs Dropped by Insurance in 2016, Including Viagra and Qsymia

Elizabeth Davis - August 12, 2015

It’s that time again—the new lists of covered and excluded drugs on next year’s insurance plans are out, and it doesn’t look great. For many Americans with health insurance, more than 50 popular brand-name and generic drugs may no longer be covered starting in January 2016.

Express Scripts and Caremark, companies that handles pharmacy benefits for more than 200 million Americans, are removing about 20 – 30 drugs each from their national preferred formularies at the end of 2015. See More

Ketoacidosis Warning Issued for New Diabetes Meds

Roni Shye - May 21, 2015

On May 15, 2015, the FDA issued a warning for the newest class of diabetes medications, SGLT2 inhibitors.

According to the FDA, the medications in this class may lead to a serious and life-threatening condition known as ketoacidosis.

Which medications are considered SGLT2 inhibitors?

These medications also contain SGLT2 inhibitors in combination with other active ingredients:

What should I do if I am taking one of these medications?

If you are taking one of the medications listed above DO NOT stop your medication without talking to your doctor. See More

What’s Invokana? 10 Things You Need to Know

Dr. Sharon Orrange - September 30, 2014

Invokana (canagliflozin) is one of the new oral medications for adult onset diabetes. It’s expensive but has many upsides. Taken usually in combination with metformin it is a rising star in the treatment of diabetes. Here is what you need to know to help you decide: worth it or not?

  1. Invokana is taken as a 100 mg tablet once daily before breakfast, increasing to a 300 mg tablet once a day if you have normal kidney function.
  2.  See More

New Diabetes Treatment Approved: Jardiance

Roni Shye - August 08, 2014

Jardiance (empagliflozin) was approved by the FDA on August 1, 2014 for the treatment of type 2 diabetes.

What type of medication is Jardiance?
Jardiance is part of a new class of medications recently approved by the FDA, Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitors.

How does Jardiance work?

It works with the body’s natural process of urination to help remove more excess sugar from the body rather than allowing it to be reabsorbed by your kidneys. See More

Farxiga Approved By the FDA for Type II Diabetes

Roni Shye - January 10, 2014

Farxiga (dapagliflozin) was approved by the FDA for the treatment of type II diabetes this week, after a previous denial in January 2012 due to bladder cancer concerns. Here’s what you need to know:

How does Farxiga work, and are there any similar drugs available?

Dapagliflozin is part of a newer class of drugs: Sodium Glucose Co-Transporter 2 inhibitors (SGLT2 inhibitors). Invokana (canagliflozin), approved in March 2013, is the only other medication in this class. See More

GoodRx is not sponsored by or affiliated with any of the pharmacies identified in its price comparisons. All trademarks, brands, logos and copyright images are property of their respective owners and rights holders and are used solely to represent the products of these rights holders. This information is for informational purposes only and is not meant to be a substitute for professional medical advice, diagnosis or treatment. GoodRx is not offering advice, recommending or endorsing any specific prescription drug, pharmacy or other information on the site. GoodRx provides no warranty for any of the pricing data or other information. Please seek medical advice before starting, changing or terminating any medical treatment.
In all states except Tennessee, GoodRx is considered a marketer of prescription discount cards, and is not required to register as a discount card provider. In Tennessee, GoodRx is registered as a Prescription Drug Discount Plan Operator.
Safe Pharmacy